[Effect and safety of transrectal 137 CS gamma-rays in the treatment of benign prostatic hyperplasia].
To evaluate the effect and safety of transrectal 137Cs gamma-ray therapy for benign prostatic hyperplasia. Thirty cases of BPH were treated by transrectal 137Cs gamma-rays. After 6 months there was significant improvement in the maximum urine flow, IPSS and QOL (P < 0.05). But no significant changes were observed in the prostate volume and residual urine (P > 0.05). Transrectal 137Cs gamma-ray therapy is safe and effective in the treatment of BPH.